SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-103878
Filing Date
2019-04-11
Accepted
2019-04-11 16:21:03
Documents
6
Period of Report
2019-05-31
Effectiveness Date
2019-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A d713258ddef14a.htm DEF 14A 606663
2 GRAPHIC g713258g04b68.jpg GRAPHIC 20595
3 GRAPHIC g713258g37t46.jpg GRAPHIC 5979
4 GRAPHIC g713258g51k98.jpg GRAPHIC 107751
5 GRAPHIC g713258g61p61.jpg GRAPHIC 35260
6 GRAPHIC g713258g96m30.jpg GRAPHIC 30388
  Complete submission text file 0001193125-19-103878.txt   883818
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37553 | Film No.: 19744077
SIC: 2836 Biological Products, (No Diagnostic Substances)